New study tracks cancer risk in rare genetic condition
NCT ID NCT05630105
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 430 people with Cowden's disease (a PTEN gene mutation) to better understand their risk of developing cancer. Researchers will track how many participants get cancer over time. The goal is to improve monitoring and care for this high-risk group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COWDEN SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
1-CHU Amiens
Amiens, France
-
10-CHU Colmar
Colmar, France
-
11-CHU Dijon
Dijon, France
-
12-CHU Grenoble
Grenoble, France
-
13a-AP-HP Hôpital Avicenne
Paris, France
-
13b-AP-HP Hôpital Saint-Antoine
Paris, France
-
13c-APH-HP Hôpital Salpétrière
Paris, France
-
13d-AP-HP Hôpital Trousseau
Paris, France
-
13e-AP-HP Hôpital Saint-Louis
Paris, France
-
13f-AP-HP Hôpital Robert Debré
Paris, France
-
14-Institut Curie
Paris, France
-
15-Institut Gustave Roussy
Villejuif, France
-
16-CHU Lille
Lille, France
-
17-CHU Limoges
Limoges, France
-
18a-Hospices Civils Lyon - Lyon Est
Lyon, France
-
18b-Hospices Civils Lyon - Lyon Sud
Lyon, France
-
19-AP-HM Hôpital de la Timone
Marseille, France
-
2-CHU Angers
Angers, France
-
20-CHU Montpellier
Montpellier, France
-
21-CHU Nantes
Nantes, France
-
22-CHU Nice
Nice, France
-
23-CHU Nîmes
Nîmes, France
-
24-CHU Poitiers
Poitiers, France
-
25-Institut du Cancer Courlancy
Reims, France
-
26-Centre Eugène Marquis
Rennes, France
-
27-CHU Rennes
Rennes, France
-
28-CHU Saint-Etienne
Saint-Etienne, France
-
29-Institut Strauss
Strasbourg, France
-
3-ICO Angers et Nantes
Angers, France
-
30-CHU Toulouse
Toulouse, France
-
31-CHU Tours
Tours, France
-
32-Centre Antoine Lacassagne
Nice, France
-
33-Institut Paoli Calmettes
Marseille, France
-
34-CH Valence
Valence, France
-
35-CHU Rouen
Rouen, France
-
36-CH Le Mans
Le Mans, France
-
37-CH Niort
Niort, France
-
38-CHU Guadeloupe
Pointe à Pitre, France
-
4-CHU Besançon
Besançon, France
-
40-CHU Troyes
Troyes, France
-
5-CHU Bordeaux
Bordeaux, France
-
6-Institut Bergonié
Bordeaux, France
-
7-CHU Brest
Brest, France
-
8-Centre François Baclesse
Caen, France
-
9-CH Métropole Savoie Chambéry
Chambéry, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.